株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

インスリンポンプ(体外式)の世界市場

Insulin Pumps (External)

発行 Global Industry Analysts, Inc. 商品コード 138674
出版日 ページ情報 英文 135 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
インスリンポンプ(体外式)の世界市場 Insulin Pumps (External)
出版日: 2014年03月01日 ページ情報: 英文 135 Pages
概要

当レポートでは、世界のインスリンポンプ(体外式)市場について調査し、地域別の包括的動向、2013〜2020年の予測、参入企業のプロファイルをまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション、調査方法、製品定義

第2章 エグゼクティブサマリー

  • 業界概要
    • インスリンポンプ:概要
    • 米国:最大市場
    • 欧州:大きな潜在性をもつ市場
    • 糖尿病罹患率の上昇:けん引因子
  • 競合分析
    • インスリンポンプ市場:関心深い市場
    • メーカー別インスリンポンプの比較
    • パッチポンプ市場で激化する競争
    • 新規参入企業にとっての厳しい地盤
  • 市場動向と課題
    • スマートポンプの台頭
    • 人工膵臓システム:将来的糖尿病ケア
    • 2型糖尿病:大きな可能性のある市場
    • 高齢者層の糖尿病リスクがインスリンポンプの機会に
    • 警告的肥満人口の増加:糖尿病ケアのビジネス事例 他
  • 課題
    • 埋め込みインスリンポンプ
    • インスリンポンプトレーニング
    • 複雑なインスリンポンプソフトが高齢者にとっての使いづらさに
    • 他のインスリンデリバリー技術との競合はつづく
    • 未診断の糖尿病
    • Lantus:インスリンポンプメーカーにとっての脅威
  • 糖尿病発症率と罹患率
  • 糖尿病とインスリン:概要
  • 製品概要
  • 製品革新/イントロダクション
  • 近年の業界の動き
  • 主要企業
    • Animas Corp.
    • Debiotech S.A.
    • F. Hoffmann-La Roche, Ltd.
    • Insulet Corp.
    • Medtronic
    • Medtronic Diabetes
    • Sooil Development Co. Ltd.
    • Tandem Diabetes Care Inc.
    • Valeritas Inc.
    • Ypsomed Holding AG
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-1511

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 13 companies including many key and niche players such as -

Animas Corp.
Debiotech S.A
F. Hoffmann-La Roche, Ltd.
Insulet Corp.
Medtronic

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Insulin Pumps: A Prelude
  • The United States - The Largest Market
  • Europe - A Market with Vast Potential
  • Rising Incidence of Diabetes - The Driving Factor
    • Table 1: Worldwide Prevalence of Diabetes Mellitus by Region: 2013 & 2035 P (includes corresponding Graph/Chart)

2. COMPETITIVE ANALYSIS

  • Insulin Pumps Market - Set for Interesting Road Ahead
    • Table 2: Global External Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), and Others (includes corresponding Graph/Chart)
    • Table 3: Global Market for External Insulin Pumps by Leading Players (2014E): Percentage Share Breakdown of Value Sales for Medtronic, Insulet, Roche, J&J (Animas), Tandem and Others (includes corresponding Graph/Chart)
  • Comparison of Select Insulin Pumps by Manufacturer
  • Competition Heats Up in the Patch Pumps Market
  • Tough Ground for New Entrants

3. MARKET TRENDS AND ISSUES

  • The Rise of Smart Pumps - A Major Game Changer
  • Artificial Pancreas System (APS) - The Future of Diabetes Care
  • Type II Diabetes - A Market with Significant Potential
  • The Risk of Diabetes in Aging Populace Presents Opportunities for Insulin Pumps
    • Table 4: Global Population Statistics for the 65+ Age Group (Male & Female) for Major Countries/Regions: 2013E (includes corresponding Graph/Chart)
  • Alarming Rise in Obesity - A Business Case for Diabetes Care
    • Table 5: Obesity Rates (%) in OECD Countries (includes corresponding Graph/Chart)
    • Table 6: Obese and Overweight & Obese Population in the World (2013): Percentage Share Breakdown by Region for US, European Union, and Rest of World (includes corresponding Graph/Chart)
  • Diabetes in Developing Countries to Expand Opportunities
  • Innovative Features Spruce Up the Market for Insulin Pumps
  • Patch Pumps Gain Manufacturer Attention
  • ICR: A Key Factor to Success
  • Expiry of Warranty Provides New Opportunities to Insulin Pump Makers
  • Teenagers Outdo Adults in Controlling Diabetes
  • Customer Satisfaction: Crucial to Stay Competitive

4. CHALLENGES

  • Implantable Insulin Pumps - A Potential Threat to External Insulin Pumps
  • Insulin Pump Training - Not Receiving Adequate Attention
  • Complicated Insulin Pump Software Makes Pump Use Difficult for the Aged
  • Competition from Other Insulin Delivery Technologies Continues
  • Undiagnosed Diabetes - A Key Challenge
  • Lantus: A Threat to Insulin Pump Manufacturers

5. DIABETES- INCIDENCE AND PREVALENCE

    • Table 7: Global Diabetic Population by Region (2013 & 2035) (includes corresponding Graph/Chart)
    • Table 8: Top Ten Diabetic Countries (2013) by Number of Individuals with Diabetes (includes corresponding Graph/Chart)
    • Table 9: Top Ten Countries by Diabetic Population (2035) (includes corresponding Graph/Chart)
  • Diabetes - Assessing the Economic Burden
    • Table 10: Diabetes Related Healthcare Expenditure by Region: 2013 (In US$ billion) (includes corresponding Graph/Chart)
  • Diabetes Mellitus Cases Worldwide - A Demographic Analysis by Geographic Region
  • North America
    • United States
    • Canada
    • Mexico
    • Table 11: Prevalence of Diabetes Mellitus in North America (2035 P): Breakdown by Country, Age Group, and Gender (In Thousand People & %) (includes corresponding Graph/Chart)
  • Europe
    • Table 12: Prevalence of Diabetes Mellitus in Europe (2035P): Breakdown by Country, Age Group, and Gender (In Thousand People & %)
  • Asia-Pacific
    • Southeast Asian Region
    • Western Pacific Region
  • South & Central America
    • Type-1 Diabetes
    • Type-2 Diabetes

6. DIABETES & INSULIN - AN ABSTRACT

  • Diabetes - A Fatal Disease
  • Risk Factors for Diabetes
  • Types of Diabetes
  • Long Term Complications of Diabetes
  • Testing Sugar Levels: Easy and Accurate
  • Insulin
  • Pancreas: The Main Source of Insulin in Human Body
  • Types of Insulin
    • Types of Insulin & Onset of Action
  • Goal of Insulin Therapy
  • Insulin Delivery Systems
    • Table 13: Global Insulin Delivery Devices Market by Leading Players (2013): Percentage Market Share Breakdown for Medtronic, Novo Nordisk, Sanofi and Others (includes corresponding Graph/Chart)
  • a. Syringes
  • b. Insulin Pens
  • c. Jet Injectors
  • d. Tablets
  • e. External Insulin Pumps
  • f. Artificial Pancreas
  • Insulin Delivery Technologies

7. PRODUCT OVERVIEW

  • Evolution of Insulin Pumps
  • Insulin Pump - A Replica of Pancreas
  • Advantages
  • More Accurate and Consistent
  • Enhances Blood Sugar Control in Pediatric Patients
  • Adjusting Time Zones While Traveling
  • Improves Quality of Life
  • Patient Convenience
  • Components of Insulin Pump
  • How Does an Insulin Pump Work?
  • Value-added Features of Modern Insulin Pumps
    • Bolus Calculators
    • Insulin On Board
    • Customized Alarms
    • Touch Bolus
    • Interface to PCs
    • Others
  • Insulin Pump Delivery Rates
  • Guidelines for Insulin Pump Usage
  • Disadvantages/Risks Involved in the Usage of Insulin Pumps
  • High Cost
  • High Involvement
  • Diabetic Ketoacidosis Risk
  • Glucose Testing at Regular Intervals
  • Regular Rotation of Infusion Set
  • Carrying Back-up Kit
  • Regular Refilling of Pump

8. PRODUCT INNOVATIONS/INTRODUCTIONS

  • Debiotech to Unveil Jewel Pump 2
  • Cellnovo Introduces Novel Insulin Pump System
  • J&J Introduces Animas Vibe in Canada
  • Tandem Introduces New Insulin Pump, t:slim, with a Touch Screen

9. RECENT INDUSTRY ACTIVITY

  • Roche and Novo Nordisk Team Up for Insulin Pump Cartridge
  • Medtronic Secures FDA Approval for MiniMed 530G
  • LifeScan Acquires Calibra Medical
  • Mediq Takes Over Diabetes Specialty Center
  • Indutrade to Acquire Rubin Medical
  • Cellnovo Obtains CE Mark for Patch Pump
  • Asante Secures 510 (K) Approval
  • Medtronic and Bayer HealthCare Expand Collaboration to Cover US Market
  • Insulet Acquires Neighborhood Diabetes
  • JDRF Enters into Partnership with Animas
  • JDRF Collaborates with BD
  • Insulet Inks Exclusive Distribution Agreement with Ypsomed
  • Roche Takes Over Medingo

10. FOCUS ON SELECT KEY PLAYERS

  • Animas Corp. (USA)
  • Debiotech S.A. (Switzerland)
  • F. Hoffmann-La Roche, Ltd. (Switzerland)
  • Insulet Corp. (USA)
  • Medtronic (USA)
  • Medtronic Diabetes (USA)
  • Sooil Development Co. Ltd. (Korea)
  • Tandem Diabetes Care Inc. (USA)
  • Valeritas Inc. (US)
  • Ypsomed Holding AG (Switzerland)

11. GLOBAL MARKET PERSPECTIVE

    • Table 14: World Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 15: World Historic Review for Insulin Pumps (External) by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 16: World 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (exc. Japan), Latin America, and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Table 17: US Market Proliferation of Insulin Pumps in Type I Diabetes Treatment (2010-2017P) (includes corresponding Graph/Chart)
    • Surging Diabetic Population Spurs Demand
    • Table 18: US Diabetics Population (2010-2017): Percentage Population with Diagnosed and Undiagnosed Diabetes (includes corresponding Graph/Chart)
    • Table 19: US Market for Diabetes Management (2014E & 2017P): Percentage Share Breakdown by Treatment Type (includes corresponding Graph/Chart)
    • Table 20: Diabetes Prevalence by Ethnicity (includes corresponding Graph/Chart)
    • Table 21: US Diabetes Prevalence (in 000's) for 2010-2017P (includes corresponding Graph/Chart)
    • Table 22: Diabetes Prevalence in the US by Type: 2013 (includes corresponding Graph/Chart)
    • Artificial Pancreas System (APS): The Future of Diabetes Management
      • Select Ongoing Clinical Studies on Artificial Pancreas Technology
    • Competitive Scenario
    • Table 23: The US Insulin Pumps Market by Leading Players (2013): Percentage Market Share Breakdown of Value Sales for Medtronic, Animas (J&J), Insulet, and Others (includes corresponding Graph/Chart)
    • Table 24: Major Insulin Pump Systems Available in the US
    • Reimbursements
    • Regulatory Scenario
      • FDA Announces a New Mandate for Manufacturing Companies
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 25: The US Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 26: The US Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 27: Canadian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 28: Canadian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • Market Analysis
    • Table 29: Japanese Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 30: Japanese Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Regional Scenario
    • Diabetes Prevalence in Europe
    • Table 31: Diabetes Mellitus in Europe (2013 & 2035P): Percentage Breakdown of Prevalence in Population by Country (includes corresponding Graph/Chart)
    • Table 32: Percentage of Population with Diabetes and Prevalence of Diabetes in the EU (2009-2015) (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 33: European Recent Past, Current & Future Analysis for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 34: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 35: European 15-Year Perspective for Insulin Pumps (External) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 36: French Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: French Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analysis
    • Table 38: German Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: German Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 40: Italian Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: Italian Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • INPUT (The Insulin Pump Therapy Group)
    • NICE (National Institute of Clinical Excellence)
    • Product Launch
  • B. Market Analytics
    • Table 42: The UK Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: The UK Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 44: Spanish Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 45: Spanish Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Russia
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 46: Rest of European Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 47: Rest of European Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Table 48: Diabetes Mellitus in Asia-Pacific (2013 & 2035 P): Percentage Breakdown of Prevalence by Select Countries (includes corresponding Graph/Chart)
    • Review of Select Markets
      • India
      • Diabetes Scenario
      • Insulin Pumps Gather Momentum
      • Medtronic: The Undisputed Market Leader
      • Diabetic Epidemic Spurs Indian Market
      • China
      • Overview
      • Competition
      • China: An Untapped Goldmine
    • Key Player
  • B. Market Analytics
    • Table 49: Asia-Pacific Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Asia-Pacific Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Brazil
  • B. Market Analytics
    • Table 51: Latin American Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 52: Latin American Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • UAE
      • Demand for Insulin Pumps Grows Strongly in the UAE
    • Product Launch
  • B. Market Analytics
    • Table 53: Rest of World Recent Past, Current & Future Analysis for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Rest of World Historic Review for Insulin Pumps (External) Market Analyzed with Annual Sales Figures in US$ Thousands for Years 2006 through 2012 (includes corresponding Graph/Chart)
Back to Top